Literature DB >> 30787153

Structure of Parvovirus B19 Decorated by Fabs from a Human Antibody.

Yingyuan Sun1, Thomas Klose1, Yue Liu1, Susanne Modrow2, Michael G Rossmann3.   

Abstract

Parvovirus B19, one of the most common human pathogens, is a small DNA virus that belongs to the Parvoviridae As a result of previous infections, antibodies to B19 are present in most adults. B19 has a strong tropism to erythroid progenitor cells and is able to cause a series of medical conditions, including fifth disease, arthritis, myocarditis, hydrops fetalis, and aplastic crisis. No approved vaccine is currently available for B19, and there is a lack of structural characterization of any B19 epitopes. Here we present the first cryo-electron microscopy (cryo-EM) structure of a B19 virus-like particle (VLP) complexed with the antigen-binding fragment (Fab) of a human neutralizing antibody, 860-55D. A model was built into the 3.2-Å-resolution map, and the antigenic residues on the surface of the B19 capsid were identified. Antibody 860-55D bridges the capsid of B19 by binding to a quaternary structure epitope formed by residues from three neighboring VP2 capsid proteins.IMPORTANCE Parvovirus B19 is a common human pathogen and a particular threat to children, pregnant women, and patients with sickle cell disease or AIDS. Currently, neutralizing antibody is the most efficient treatment for acute B19 infections. Research on the antigenic properties of B19 will guide the usage of these antibodies and facilitate vaccine development. We have determined and report here the high-resolution structure of B19 virus-like particles (VLPs) complexed with the Fab of a human neutralizing antibody. The structure shows a quaternary structure epitope formed by three VP2 proteins and provides details on host recognition of human B19 virus.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  B19 parvovirus; cryo-EM; epitope; human antibody

Mesh:

Substances:

Year:  2019        PMID: 30787153      PMCID: PMC6475792          DOI: 10.1128/JVI.01732-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

2.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

3.  Visualization of the externalized VP2 N termini of infectious human parvovirus B19.

Authors:  Bärbel Kaufmann; Paul R Chipman; Victor A Kostyuchenko; Susanne Modrow; Michael G Rossmann
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

4.  Near-Atomic Resolution Structure of a Highly Neutralizing Fab Bound to Canine Parvovirus.

Authors:  Lindsey J Organtini; Hyunwook Lee; Sho Iketani; Kai Huang; Robert E Ashley; Alexander M Makhov; James F Conway; Colin R Parrish; Susan Hafenstein
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

5.  Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection.

Authors:  C E Wobus; B Hügle-Dörr; A Girod; G Petersen; M Hallek; J A Kleinschmidt
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease).

Authors:  T Chorba; P Coccia; R C Holman; P Tattersall; L J Anderson; J Sudman; N S Young; E Kurczynski; U M Saarinen; R Moir
Journal:  J Infect Dis       Date:  1986-09       Impact factor: 5.226

7.  Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity.

Authors:  Claudia Bönsch; Christoph Kempf; Carlos Ros
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

8.  VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones.

Authors:  Claudia Filippone; Ning Zhi; Susan Wong; Jun Lu; Sachiko Kajigaya; Giorgio Gallinella; Laura Kakkola; Maria Söderlund-Venermo; Neal S Young; Kevin E Brown
Journal:  Virology       Date:  2008-02-05       Impact factor: 3.616

9.  Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry.

Authors:  Kirsten A Weigel-Kelley; Mervin C Yoder; Arun Srivastava
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

10.  The structure of a neutralized virus: canine parvovirus complexed with neutralizing antibody fragment.

Authors:  W R Wikoff; G Wang; C R Parrish; R H Cheng; M L Strassheim; T S Baker; M G Rossmann
Journal:  Structure       Date:  1994-07-15       Impact factor: 5.006

View more
  3 in total

Review 1.  Parvovirus Capsid-Antibody Complex Structures Reveal Conservation of Antigenic Epitopes Across the Family.

Authors:  Shanan N Emmanuel; Mario Mietzsch; Yu Shan Tseng; James Kennon Smith; Mavis Agbandje-McKenna
Journal:  Viral Immunol       Date:  2020-04-21       Impact factor: 2.257

2.  Parvovirus B19 Uncoating Occurs in the Cytoplasm without Capsid Disassembly and It Is Facilitated by Depletion of Capsid-Associated Divalent Cations.

Authors:  Oliver Caliaro; Andrea Marti; Nico Ruprecht; Remo Leisi; Suriyasri Subramanian; Susan Hafenstein; Carlos Ros
Journal:  Viruses       Date:  2019-05-10       Impact factor: 5.048

Review 3.  Advances in the Development of Antiviral Strategies against Parvovirus B19.

Authors:  Elisabetta Manaresi; Giorgio Gallinella
Journal:  Viruses       Date:  2019-07-18       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.